These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 30191494

  • 1. The association of PRECISE-DAPT score with development of contrast-induced nephropathy in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Çınar T, Tanık VO, Aruğaslan E, Karabağ Y, Çağdaş M, Rencüzoğulları İ, Keskin M.
    Cardiovasc Interv Ther; 2019 Jul; 34(3):207-215. PubMed ID: 30191494
    [Abstract] [Full Text] [Related]

  • 2. Association of Serum Osmolarity With Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction.
    Yildiz I, Yildiz PO, Rencuzogullari I, Karabag Y, Cagdas M, Burak C, Gurevin MS.
    Angiology; 2019 Aug; 70(7):627-632. PubMed ID: 30712366
    [Abstract] [Full Text] [Related]

  • 3. The Predictive Value of PRECISE-DAPT Score for In-Hospital Mortality in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Tanik VO, Cinar T, Arugaslan E, Karabag Y, Hayiroglu MI, Cagdas M, Rencuzogullari I, Uluganyan M.
    Angiology; 2019 May; 70(5):440-447. PubMed ID: 30322265
    [Abstract] [Full Text] [Related]

  • 4. Predictive Value of Gamma-Glutamyl Transferase Levels for Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.
    Oksuz F, Yarlioglues M, Cay S, Celik IE, Mendi MA, Kurtul A, Cankurt T, Kuyumcu S, Canpolat U, Turak O.
    Am J Cardiol; 2015 Sep 01; 116(5):711-6. PubMed ID: 26116992
    [Abstract] [Full Text] [Related]

  • 5. Comparison of Different Risk Scores for Predicting Contrast Induced Nephropathy and Outcomes After Primary Percutaneous Coronary Intervention in Patients With ST Elevation Myocardial Infarction.
    Liu YH, Liu Y, Zhou YL, He PC, Yu DQ, Li LW, Xie NJ, Guo W, Tan N, Chen JY.
    Am J Cardiol; 2016 Jun 15; 117(12):1896-903. PubMed ID: 27161818
    [Abstract] [Full Text] [Related]

  • 6. Utility of the Logistic Clinical Syntax Score in the Prediction of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.
    Ozturk D, Celik O, Erturk M, Kalkan AK, Uzun F, Akturk IF, Akin F, Yildirim A.
    Can J Cardiol; 2016 Feb 15; 32(2):240-6. PubMed ID: 26255218
    [Abstract] [Full Text] [Related]

  • 7. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Andò G, Morabito G, de Gregorio C, Trio O, Saporito F, Oreto G.
    Catheter Cardiovasc Interv; 2013 Nov 15; 82(6):878-85. PubMed ID: 23703775
    [Abstract] [Full Text] [Related]

  • 8. Fragmented QRS complex predicts contrast-induced nephropathy and in-hospital mortality after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Kurtul A, Duran M.
    Clin Cardiol; 2017 Apr 15; 40(4):235-242. PubMed ID: 28244599
    [Abstract] [Full Text] [Related]

  • 9. Association of contrast-induced nephropathy with bare metal stent restenosis in STEMI patients treated with primary PCI.
    Güngör B, Karataş MB, İpek G, Özcan KS, Çanga Y, Onuk T, Keskin M, Hayıroğlu Mİ, Karadeniz FÖ, Sungur A, Öztürk R, Bolca O.
    Ren Fail; 2016 Sep 15; 38(8):1167-73. PubMed ID: 27436614
    [Abstract] [Full Text] [Related]

  • 10. A simple risk score model for predicting contrast-induced nephropathy after coronary angiography in patients with diabetes.
    Zeng JF, Chen SQ, Ye JF, Chen Y, Lei L, Liu XQ, Liu Y, Wang Y, Lin JJ, Chen JY.
    Clin Exp Nephrol; 2019 Jul 15; 23(7):969-981. PubMed ID: 31049747
    [Abstract] [Full Text] [Related]

  • 11. Canada Acute Coronary Syndrome Score: A Preprocedural Risk Score for Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.
    Liu YH, Jiang L, Duan CY, He PC, Liu Y, Tan N, Chen JY.
    Angiology; 2017 Oct 15; 68(9):782-789. PubMed ID: 28135823
    [Abstract] [Full Text] [Related]

  • 12. CHA2DS2-VASc score predicts contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction, who have undergone primary percutaneous coronary intervention.
    Cicek G, Yıldırım E.
    Kardiol Pol; 2018 Oct 15; 76(1):91-98. PubMed ID: 28980300
    [Abstract] [Full Text] [Related]

  • 13. CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.
    Wang Y, Zhao HW, Zhang XJ, Chen BJ, Yu GN, Hou AJ, Luan B.
    BMC Cardiovasc Disord; 2019 Mar 29; 19(1):74. PubMed ID: 30922230
    [Abstract] [Full Text] [Related]

  • 14. Inter-arm blood pressure difference is associated with contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention.
    Simsek Z, Zehir R, Kalkan S, Ceneli D, Alizade E, Bayam E, Candan Ö.
    Clin Exp Hypertens; 2022 Apr 03; 44(3):258-262. PubMed ID: 35060428
    [Abstract] [Full Text] [Related]

  • 15. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
    Nakahashi H, Kosuge M, Sakamaki K, Kiyokuni M, Ebina T, Hibi K, Tsukahara K, Iwahashi N, Kuji S, Oba MS, Umemura S, Kimura K.
    Heart Vessels; 2017 Jan 03; 32(1):22-29. PubMed ID: 27106917
    [Abstract] [Full Text] [Related]

  • 16. Predictive value of ATRIA risk score for contrast-induced nephropathy after percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Aksoy F, Bagcı A.
    Rev Assoc Med Bras (1992); 2019 Nov 03; 65(11):1384-1390. PubMed ID: 31800901
    [Abstract] [Full Text] [Related]

  • 17. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
    Mager A, Vaknin Assa H, Lev EI, Bental T, Assali A, Kornowski R.
    Catheter Cardiovasc Interv; 2011 Aug 01; 78(2):198-201. PubMed ID: 20949583
    [Abstract] [Full Text] [Related]

  • 18. Effects of Serum Cytochrome c on Contrast-Induced Nephropathy in Patients with ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Tang C, Hou J, Yan G, Qiao Y, Wang D, Zhu B, Liu B, Luo E, Nawabi AQ, Chen L.
    Biomed Res Int; 2019 Aug 01; 2019():9357203. PubMed ID: 30809550
    [Abstract] [Full Text] [Related]

  • 19. A Delta Neutrophil Index for the Prediction of Contrast-Induced Nephropathy in Patients With St-Elevation Myocardial Infarction Followed By Percutaneous Coronary Intervention.
    Kong T, Park YS, Lee HS, Kim S, Han S, Eun CH, Lee JW, You JS, Chung HS, Park I, Chung SP.
    Shock; 2018 Mar 01; 49(3):317-325. PubMed ID: 28885386
    [Abstract] [Full Text] [Related]

  • 20. Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
    Liu Y, Hong D, Wang AY, Guo R, Smyth B, Liu J, Sun G, Chen S, Tan N, Jardine M, Brieger D, Shaman A, Islam S, Chen J, Gallagher M.
    BMC Cardiovasc Disord; 2019 Apr 08; 19(1):87. PubMed ID: 30961544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.